Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)

Clinical trial NCT07713745 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07713745
Sponsor: Beijing Tiantan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis Type 2 Vestibular Schwannoma Non-vestibular Schwannoma Meningioma Ependymoma NF2-related Schwannomatosis NF2

Start date: 2026-07-18
Primary completion: 2036-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.